Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis

Overview of attention for article published in Frontiers in endocrinology, September 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 1 X post from an account with 4,827 followers.

New Research: Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis: Background: Survival rates for anaplastic thyroid cancer (ATC) have not improved in the past… https://t.co/nC6S3dPE9

03 Sep 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.